Key leadership appointments at Catalyst Health Network reflect the organization’s continued growth, advancement and innovation
Key Leadership Appointments at Catalyst Health Network Reflect the Organization’s Continued Growth, Advancement and Innovation
Plano, Texas, Jan. 24, 2022 – Catalyst Health Group—a champion for primary care access, innovation and investment—announces three new, senior leadership roles within Catalyst Health Network. This leadership expansion spotlights the ongoing growth and impact of the Network, which today encompasses more than 1,000 providers, serving more than 1.5 million patients and generating more than $100 million in community savings.
Dr. Michelle Forbes, formerly a medical director for Catalyst Health Network, will now serve as Chief Medical Officer for the organization, where she will lead the Network’s team of medical directors and set clinical direction and best practices for the largest clinically integrated network for primary care providers in the Southwest.
Concurrent to this role, Dr. Forbes will also serve as Chief Medical Officer for the Catalyst Community Foundation, leading strategic direction and building collaborative partnerships with local organizations to expand the Foundation’s impact through community-based sites for primary care and pharmacy services.
Dr. Forbes assumes her role as Chief Medical Officer for Catalyst Health Network from Dr. Jeff Bullard, who has stepped into a new role at Catalyst Health Group: Chief Product Strategy Officer. In his role, Dr. Bullard will lead product development and advancement to create outsized value for all stakeholders. With more than 20 years of experience, Dr. Bullard is nationally recognized as a leading innovator in building solutions that leverage technology to enable human-centered, relationship-driven care delivery.
Dr. Matt Weyenberg joins the organization to serve as Chief Medical Officer for Catalyst Senior Health Network, driving Network engagement and performance among this Medicare-focused portion of Catalyst’s physician membership. Dr. Weyenberg previously served as Senior Market Medical Director at WellMed. Prior to that, he was cofounder and Chief Medical Information Officer of Village Health Partners in Plano, Texas, where he worked in private practice for 12 years alongside Dr. Christopher Crow, CEO of Catalyst Health Group.
Jenna Hemmingway, Senior Vice President of Network Strategy and Operations, will also assume the role of Executive Director for Catalyst Health Network. With more than 10 years of healthcare provider relations and business development leadership—the last seven of which at Catalyst—Jenna will lead the Network to advance value-based care, while developing and executing operational and growth strategies for Network effectiveness and expansion.
“Appointing these leaders to their new roles showcases the quality of Catalyst Health Network and the progression of impact that we’re having on the way primary care is delivered and the role it can have on patient lives,” said Dr. Christopher Crow, CEO of Catalyst Health Group. “As Catalyst continues to innovate to improve the health experiences, outcomes and economics for all, we expect these leaders to be instrumental in fulfilling our organization’s purpose of helping communities thrive.”
For more information, visit catalysthealthgroup.net.
About Catalyst Health Group
Catalyst Health Group enables primary care to be the difference-maker in patients’ lives that it was always meant to be. As the creator of Texas’ largest clinically integrated network for primary care providers, Catalyst’s team supports more than 1.5 million patients in every moment that matters. Our work improves patient health and reduces overall costs in sustainable, scalable ways. Together, we help communities thrive. For more information visit our website and follow us on Twitter and LinkedIn.
Last year saw $41 billion invested in digital health companies. That’s billions and billions of dollars put toward innovating and improving a healthcare system that virtually all stakeholders believe is in desperate need of reimagination, reconstruction and revolution.
Pharmacists acting as an extension of physicians’ care teams is a key component of the tech-enabled, integrated care team I described above. Medication errors, poor adherence, incomplete treatment plans, and lack of communication around prescriptions have significant implications on the health of patients and contribute to rising costs. By integrating…